Hepatocyte precursor cell lines

• US 8,404,481 B2
• Filed: 11/16/2009
• Issued: 03/26/2013
• Est. Priority Date: 02/15/2002
• Status: Active Grant

• Current Assignee: Massachusetts Institute of Technology
• Original Assignee: Massachusetts Institute of Technology
• Inventors: Sherley, James L., Lee, Hsuan-Shu, Crane, Gracy G.
• Primary Examiner(s): Afremova, Vera
• Application Number:
  US12/619,107
• Publication Number:
  US 20100086936A1
• Time in Patent Office: 1,226 Days
• Field of Search: None
• US Class Current: 435/370
• CPC Class Codes: A61P 1/16 for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• CPC Class Codes: C12N 2500/40 Nucleotides, nucleosides, bases cyclic nucleotides C12N2501/01, anti-neoplasic drugs C12N2501/06
• CPC Class Codes: C12N 5/0672 Stem cells; Progenitor cells; Precursor cells; Oval cells

Abstract

The present invention is directed to methods for readily generating hepatocyte precursor cell lines that retain hepatocyte-specific functions after extensive in vitro culturing. The methods comprise isolating and culturing hepatocyte precursor cell lines under permissive culture conditions that suppress asymmetric cell kinetics and allow exponential growth of the precursor cells, followed by transferring the hepatocyte precursor cell lines to non-permissive culture conditions that allow expression of asymmetric cell kinetics and induce expression of hepatocyte-specific characteristics.

Claims

1. A method of preparing hepatic cells that express mature hepatic cell markers comprising:

a) culturing a population of cells from liver tissue obtained from a mammal, wherein the population of cells comprises stellate cells, hepatocytes, cholangiocytes, oval cells, Kupffer cells, sinusoidal endothelial cells and hepatic precursor cells,

b) enriching the population of cells for hepatic precursor cells,

c) culturing the enriched population of cells in a first culture medium comprising a guanine nucleotide precursor of at least 50 μ

M, or an analogue or derivative thereof, wherein said guanine nucleotide precursor suppresses asymmetric cell kinetics thereby allowing exponential growth of said hepatic precursor cells;

d) passaging said cultured hepatic precursors in the culture medium of step (c) to allow expansion of said hepatic precursor cells; and

e) contacting the expanded hepatic precursors of step (c) with a second culture medium that is free from the guanine nucleotide precursor of the first medium, and selecting cells with expression of a mature hepatic cell marker, wherein the hepatic cell marker is selected from the group consisting of;

H4 antigen, α

1-antitrypsin (AAT), cytokeratin 7 (CK7), cytokeratin 8 (CK8), albumin cytochrome p450 1A1, hepatocyte nuclear transcription factor (HNF-3), CAAT enhancer-binding protein (CEBP)-alpha and CAAT enhancer-binding protein (CEBP)-beta.

2. The method of claim 1, wherein the second culture medium comprises growth factors.

3. The method of claim 1, wherein said guanine nucleotide precursor is present in an amount of 50-400 μ

M.

4. The method of claim 1, wherein the cells of step c) are cultured for a period of time exceeding 50 culture passages under conditions where the hepatic precursors cells show no evidence of neo-plastic transformation.

5. The method of claim 1, wherein the cells of step c) a cultured for at least 80 cell doublings.

6. The method of claim 1, wherein cells of step c) are cultured at a cell density of at least 1000 cells per square centimeter.